Latest News & Features
Americas
Recent patent decisions in the life sciences sector are leading biotechnology companies to seek protection for their innovations by using alternatives to patents, with trade secrets the most viable, the BIO International Convention has heard. 18 June 2015
Americas
On day three of the BIO International Convention, LSIPR spoke to Kevin Noonan and Donald Zuhn, partners at law firm McDonnell Boehnen Hulbert & Berghoff and authors of the Patent Docs blog, about the possible impact of the Federal Circuit’s Ariosa v Sequenom decision on the life sciences industry. 18 June 2015
Americas
The question of whether using a known drug for treating a known disease, but in a distinct sub-population of patients, can constitute a patentable new invention is key to the development of personalised medicine, says Stephen Smith of Potter Clarkson. 18 June 2015
Americas
Scott Kamholz, a former judge at the Patent Trial and Appeal Board, recently returned to law firm Foley Hoag as partner. LSIPR spoke to him at this year’s BIO International Convention, where he explained why the inter-partes review is not a “death squad” for patents. 18 June 2015
Americas
Australia could be going down the road of no longer allowing gene patents, New Zealand-based patent lawyer David Nowak said at the BIO International Convention yesterday. 18 June 2015
Americas
Philip Johnson, Johnson & Johnson’s senior vice president of intellectual property and policy, told the BIO International Convention yesterday that uncertainty around patent eligibility of inventions is a “silent killer of innovation”. 18 June 2015
Americas
The Transatlantic Trade and Investment Partnership has the potential to reinforce intellectual property as a driver of innovation, said Washington, DC-based former lawyer Jennifer Hillman at the BIO International Convention on Tuesday. 17 June 2015
Americas
Jacqueline Wright Bonilla, an administrative judge at the US Patent and Trademark Office, has told the BIO International Convention that despite inter partes review proceedings appearing to favour petitioners, the USPTO is not pro-petitioner, patent owner or even IPR. 17 June 2015
Americas
MultiLing is a Utah-based patent translation company with clients including IBM, Thermo Fisher Scientific and P&G. LSIPR caught up with the company’s senior vice president of worldwide sales Michael Degn at the BIO International Convention in Philadelphia. 17 June 2015
Americas
A US appeals court has affirmed that a patent covering the method of detecting foetal abnormalities in pregnant mothers is ineligible for protection because it applies to a “natural phenomenon”. 17 June 2015